Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
| 50 | 3 | PSYCHIATRY//SCHIZOPHRENIA//PSYCHIAT | 98837 |
| 421 | 2 | ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA | 16860 |
| 6436 | 1 | REDUCED HALOPERIDOL//BROMPERIDOL//HALOPERIDOL | 1513 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | REDUCED HALOPERIDOL | authKW | 599860 | 2% | 80% | 36 |
| 2 | BROMPERIDOL | authKW | 394476 | 2% | 76% | 25 |
| 3 | HALOPERIDOL | authKW | 169326 | 10% | 6% | 148 |
| 4 | REDUCED BROMPERIDOL | authKW | 145803 | 0% | 100% | 7 |
| 5 | FLUPHENAZINE DECANOATE | authKW | 88863 | 1% | 53% | 8 |
| 6 | HALOPERIDOL DECANOATE | authKW | 77132 | 1% | 37% | 10 |
| 7 | HALOPERIDOL METABOLITES | authKW | 66651 | 0% | 80% | 4 |
| 8 | BUTYROPHENONE TYPE AGENT | authKW | 62487 | 0% | 100% | 3 |
| 9 | HALOPERIDOL PYRIDINIUM | authKW | 62487 | 0% | 100% | 3 |
| 10 | KETONE REDUCTASES | authKW | 62487 | 0% | 100% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Psychiatry | 29734 | 50% | 0% | 761 |
| 2 | Pharmacology & Pharmacy | 11435 | 50% | 0% | 764 |
| 3 | Medical Laboratory Technology | 1171 | 5% | 0% | 73 |
| 4 | Toxicology | 808 | 8% | 0% | 115 |
| 5 | Chemistry, Analytical | 688 | 11% | 0% | 159 |
| 6 | Neurosciences | 606 | 14% | 0% | 210 |
| 7 | Psychology, Clinical | 402 | 4% | 0% | 62 |
| 8 | Clinical Neurology | 338 | 8% | 0% | 121 |
| 9 | Chemistry, Medicinal | 208 | 4% | 0% | 64 |
| 10 | Biochemical Research Methods | 112 | 4% | 0% | 58 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | OCTSPAN | 41658 | 0% | 100% | 2 |
| 2 | HARVEY W PETERS STUDY PARKINSONS DIS DISORD | 31240 | 0% | 50% | 3 |
| 3 | CHEM HARVEY W PETERS | 20829 | 0% | 100% | 1 |
| 4 | CHEM NEUROBIOL CHEM BIOL PROGRAM | 20829 | 0% | 100% | 1 |
| 5 | CHIM ANALYT CONTROLE MEDICAMENTS | 20829 | 0% | 100% | 1 |
| 6 | CLIN MBC 0365 | 20829 | 0% | 100% | 1 |
| 7 | CNS NEUROBIOL | 20829 | 0% | 100% | 1 |
| 8 | EA 027 | 20829 | 0% | 100% | 1 |
| 9 | FOR UNGSZENTRUM IME | 20829 | 0% | 100% | 1 |
| 10 | KLIN PSYCHIAT PK KRANKENHAUS LEIPZIG | 20829 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 38954 | 5% | 3% | 72 |
| 2 | PHARMACOPSYCHIATRIA | 29808 | 1% | 11% | 13 |
| 3 | PSYCHOPHARMACOLOGY BULLETIN | 24574 | 3% | 3% | 46 |
| 4 | THERAPEUTIC DRUG MONITORING | 21752 | 4% | 2% | 63 |
| 5 | INTERNATIONAL PHARMACOPSYCHIATRY | 12215 | 1% | 7% | 8 |
| 6 | PSYCHOPHARMACOLOGY | 10005 | 5% | 1% | 77 |
| 7 | COMMUNICATIONS IN PSYCHOPHARMACOLOGY | 7881 | 0% | 8% | 5 |
| 8 | JOURNAL OF CLINICAL PSYCHIATRY | 6379 | 3% | 1% | 47 |
| 9 | PHARMACOPSYCHIATRY | 5913 | 2% | 1% | 24 |
| 10 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 5885 | 2% | 1% | 23 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |